The use of rituximab has significantly improved outcomes for patients with B-cell malignancies. It has been shown to increase overall survival rates, prolong remission periods, and enhance the effectiveness of chemotherapy. In some cases, rituximab can be used as a maintenance therapy to help prevent cancer recurrence.
